CADMS references: R90776
Welcome to the ACCU-CHEK newsroom
For media information about Roche Diabetes Care, Inc., or about ACCU-CHEK® products and services,
please contact Anne Gill, Communications Manager, at firstname.lastname@example.org or (317) 521-4312.
03.03.2016 - Roche Diabetes Care Announces Accu-Chek® Connect Diabetes Management App Now Integrated with HealthKit
Accu-Chek Connect Integration is Part of Roche Diabetes Care’s Unwavering Commitment to Respond to the Needs of the Diabetes Community
08.04.2015 - For Parents Of Children With Diabetes, Stress Over Disease Management Has Steep Emotional Effects
New Accu-Chek® Connect Diabetes Management System Offers Peace of Mind to Parents When Their Children Are Out of Their Reach
09.16.2014 - ACCU-CHEK® Aviva Expert, the first and only stand-alone blood glucose meter system with a built-in insulin calculator, is now available
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice
02.05.2013 - Roche Diabetes Care’s ACCU-CHEK® Blood Glucose Meters Rank Highest in Overall Satisfaction in Inaugural J.D. Power and Associates Study(SM)
Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care’s ACCU-CHEK products compared with other blood glucose meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction StudySM.
Roche announced today that the ACCU-CHEK® Combo system for insulin pump therapy is now available in the United States. This market launch follows clearance from the U.S. Food and Drug Administration (FDA) for the ACCU-CHEK Combo system in July 2012. People with diabetes who are interested in learning more about the system should contact Roche Insulin Delivery Services at 1-866-382-2355.
07.18.2012 - FDA clears ACCU-CHEK® Combo system - Roche’s new interactive insulin pump system for people with diabetes
Roche announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for the ACCU-CHEK® Combo system for insulin pump therapy. The ACCU-CHEK Combo system seamlessly combines a blood glucose meter with an insulin pump, which are able to exchange data in both directions via Bluetooth wireless technology. The meter not only enables the user to quickly test blood glucose levels: It allows for operating the insulin pump remotely and by means of an easy-to-handle bolus advisor it provides support in defining the right amount of insulin. With this the ACCU-CHEK Combo system not only supports a more targeted therapy management, but it also allows for a discreet insulin administration without the need to touch the pump.
01.11.2012 - Roche receives clearance from the U.S. Food and Drug Administration for the new ACCU-CHEK® Nano SmartView blood glucose monitoring system
Roche announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its ACCU-CHEK® Nano SmartView blood glucose monitoring system. The ACCU-CHEK Nano meter uses ACCU-CHEK® SmartView test strips and will be available to customers in the first half of 2012.
INDIANAPOLIS—Roche Diabetes Care, makers of ACCU-CHEK products and services, is pleased to announce that Diabetes Living Today® Founder, President and CEO Kitty Castellini is the winner of Roche’s inaugural Diabetes Heroes’ Torchbearer Challenge.
11.30.2011 - Roche Diabetes Care Confirms Continued Supply of ACCU-CHEK® Aviva and ACCU-CHEK Aviva Plus Test Strips
INDIANAPOLIS—Roche Diabetes Care, makers of ACCU-CHEK products and services, is pleased to confirm the continued availability of its ACCU-CHEK Aviva test strip and since November 28, 2011 the ACCU-CHEK Aviva Plus test strip. Any claim related to the backorder of ACCU-CHEK Aviva or ACCU-CHEK Aviva Plus testing strips is incorrect.
04.05.2011 - Roche Diabetes Care in the U.S. Turns to Social Media to Promote Diabetes Education, Awareness and Advocacy
INDIANAPOLIS—Roche Diabetes Care, makers of ACCU-CHEK® products and services, has launched dedicated Facebook and Twitter accounts to promote diabetes education, awareness and advocacy. The company has also expanded its current Diabetes Link blog from Canada to North America.
11.11.2010 - Roche Diabetes Care Forms Human Blue Circle, Supports Viral Video for World Diabetes Day
INDIANAPOLIS—Roche Diabetes Care, makers of ACCU-CHEK® products and services, is showing its support for World Diabetes Day (Nov. 14) through two truly collaborative initiatives.
BERKELEY, CA—What started a year ago as a creative way to encourage people with diabetes to stay active has grown into a global campaign to raise awareness about the benefits of moderate exercise for people with diabetes and help fund two vital diabetes charities.
10.30.2010 - Free Diabetes Screening and Education Event Offers Assistance to More than 50 People in Birmingham
BIRMINGHAM—More than 50 people attended a free community diabetes program at the Shelby-Hoover campus of Jefferson State Community College on Saturday to learn more about the risk factors for diabetes as well as receive free health screenings.
10.23.2010 - Free Diabetes Screening and Education Event Offers Assistance to More than 200 People in Downtown Atlanta
ATLANTA—More than 200 people attended a free community diabetes program at Ebenezer Baptist Church on Saturday to learn more about the risk factors for diabetes as well as receive free health screenings.
08.06.2010 - Roche Diabetes Care Announces National Infusion Site Awareness Week, Aug. 30-Sept. 5, to Foster Better Diabetes Management and Education
Roche Diabetes Care, makers of the ACCU-CHEK® portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5..
No-Sugar Added Poetry, a breathtaking and beautiful new collection of 39 poems written by people touched by diabetes from around the world, has just been published by the Diabetes Hands Foundation
06.23.2010 - Roche Diabetes Care to Highlight Leading Patient Health and Safety Initiatives at the American Diabetes Association Annual Conference
Roche Diabetes Care, makers of the ACCU-CHEK® portfolio of diabetes management products and services, will highlight leading patient health and safety initiatives during the 70th annual American Diabetes Association Annual Conference June 26-28 in Orlando, FL.
06.01.2010 - Roche Receives “Chancellor’s Award” from Juvenile Diabetes Research Foundation International During Annual Conference
Roche, makers of ACCU-CHEK® blood glucose meters, infusion pumps, lancing devices and data management systems for people with diabetes, received the Juvenile Diabetes Research Foundation International’s “Chancellor’s Award” during the JDRF Annual Conference in Washington, D.C. The “Chancellor’s Award” recognizes and honors longstanding JDRF corporate partners.
11.23.2009 - ACCU-CHEK partners with MYLEstone Health to enhance iPhone app Glucose Buddy and web site glucosebuddy.com
Thousands of current users are now testing and logging their blood sugar results in new, more meaningful ways, using ACCU-CHEK Testing in Pairs tool with Glucose Buddy.
06.30.2009 - Roche Diabetes Care announces unique coaching program for diabetes educators as part of long-term commitment to fight the disease
Roche, the maker of ACCU-CHEK blood glucose monitoring systems and insulin pumps, announced today the latest component of its Behavior Change through Patient EngagementSM program.
Roche announces wide array of ACCU-CHEK programs centered around Behavior Change through
Patient Engagement SM , including tools for better self-care.
Rockmymeter.com allows visitors to personalize an ACCU-CHEK® Aviva meter, pick
music, make it dance and vote for their favorites.
ACCU-CHEK® Aviva System Receives Arthritis Foundation’s Ease-of-Use Commendation
02.01.2008 - Study Shows ACCU-CHEK® Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful
ACCU-CHEK Multiclix, ACCU-CHEK Softclix and ACCU-CHEK Softclix Plus lancing devices rated as least painful among leading competitive lancing devices
06.25.2007 - New data supports the increasing importance of Self-Monitoring of Blood Glucose (SMBG) in Type 2 Patients To Be Presented at the 67th American Diabetes Association Annual Meeting
New analyses and re-evaluated data, based on the Retrolective Study Self-Monitoring of Blood Glucose and Outcome in People with Type 2 Diabetes (ROSSO)1, presented at the 67th American Diabetes Association (ADA) Scientific Session, support the increasing importance of SMBG in diabetes management, delivering more detailed benefits.
1 “Self-Monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study” , Martin S et al., Diabetologia (2006) 49:271-278
CADMS references: R86218